More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

61-90 of 482 results

  • uniontherapeutics.com
  • 3
  • 3
  • 31
UNION is a clinical-stage, pharmaceutical development company focused on identifying, developing and commercializing treatments for immunology. Our current portfolio is comprised of medicinal compounds with established modes of action that hold..
Relevance: 91.07236
  • www.microbioncorp.com
  • 1
  • 9
Microbion is a clinical-stage pharmaceutical company developing a novel class of compounds for the treatment of resistant and difficult to treat infections. MBN-101, our first therapeutic candidate, has demonstrated in vitro broad spectrum, anti-..
Relevance: 90.88813
  • zetagen.com
  • 13
Zetagen is a private, clinical-stage pharmaceutical company developing innovative cancer treatments alongside osteologic interventions... Zetagen is focused on the 330,000 people in the United States and more globally, annually living with some form..
Relevance: 90.81245
  • austherabio.com
  • 1
  • 1
  • 13
Austhera is a mid-clinical stage pharmaceutical development company with a robust pipeline in oncology and rare disease. We are dramatically expanding the potential of pharmaceutical R&D by unlocking the insoluble chemical space to successful drug..
Relevance: 90.38844
  • www.bioxytraninc.com
  • 2
  • 1
  • 12
Bioxytran is a clinical stage pharmaceutical company developing platform technologies in the fields of Glycovirology, Hypoxia and Degenerative Diseases to eliminate viruses and prolong lifespan using carbohydrate drug design... BioXyTran Inc. is a..
Relevance: 90.08455
  • www.iterumtx.com
  • 3
  • 3
  • 9
Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing significantly differentiated anti-infectives aimed at combating the global crisis of multi-drug resistant (MDR) pathogens... Iterum Therapeutics plc:..
Relevance: 89.33391
  • allodynic.com
  • 1
  • 1
Allodynic is a biopharma company developing Naltrexone and acetaminophen combination for migraine and neuropathic pain treatment... Allodynic Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing naltrexone-..
Relevance: 88.471146
  • artelobio.com
  • 3
  • 4
  • 15
Artelo Biosciences, Inc. is a clinical stage pharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that modulate lipid-signaling pathways including the endocannabinoid system. Artelo is advancing a..
Relevance: 88.31429
  • www.shuttlepharma.com
  • 1
  • 1
  • 11
Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company leveraging our proprietary technology to develop novel therapies that are designed to cure cancer. Our goal is to extend the benefits of cancer treatments by leveraging insights into..
Relevance: 88.02788
  • www.luminousmindinc.com
  • 1
  • 2
  • 15
We are a clinical-stage pharmaceutical company with pioneering scientists who build product pipelines and companies that have high societal impact and transform health... Our team of "drug hunting scientists" has 100+ years of CNS drug experience...
Relevance: 87.91758
  • www.lindisbiotech.com
  • 1
  • 1
  • 2
Lindis Biotech is a clinical stage bio-pharmaceutical company, committed to develop innovative T- cell engaging trifunctional bispecific antibodies, Triomab® to turn malignant cancers into manageable and possibly curable diseases... Lindis Biotech..
Relevance: 87.093864
  • cytogelpharma.com
  • 6
  • 1
  • 13
Cytogel is a clinical stage bio-pharmaceutical company developing first-in-class drug candidates, from the novel endomorphin family of molecules, that target key pain pathways and alleviate pain. This groundbreaking approach is backed by scientific..
Relevance: 86.7416
  • tfpharma.com
  • 1
  • 2
  • 3
Techfields Inc. was founded in the mid-2000s by Chongxi Yu, Ph.D. After obtaining his doctorate in Bio-Organic chemistry from Rutgers, Dr. Yu became interested in novel methods of delivering therapeutics with the potential to decrease drug toxicity..
Relevance: 85.5363
  • www.inmedpharma.com
  • 1
  • 2
  • 17
InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. InMed's pipeline consists of three separate programs in the..
Relevance: 85.11661
  • ultimovacs.com
  • 3
  • 1
  • 28
Ultimovacs is a clinical-stage biotechnology company developing novel immunotherapies against cancer. The product candidate UV1 is an off-the-shelf therapeutic cancer vaccine designed to enhance the benefits of immunotherapy and improve cancer..
Relevance: 84.62678
  • www.neoviaoncology.com
  • 5
Neovia Oncology LLC is a USA-based clinical stage pharmaceutical company, yet, that is just a piece of the story... To date, Raymond Su and I have funded the company personally because no investor or potential pharma partner shared our vision. We..
Relevance: 84.47995
  • altesabio.com
  • 2
  • 16
Altesa is a clinical-stage pharmaceutical company dedicated to developing new treatments for age-old threats to human health: high-consequence viral infections. These infections are particularly severe in vulnerable people, including those with..
Relevance: 84.345436
  • biocidium.com
  • 3
  • 1
  • 2
Biocidium is a clinical-stage bio-pharmaceutical company focused on the discovery & development of novel antibiotics, antifungals and cancer treatments. Our primary products are developed for the treatment of multi-drug resistant (MDR) bacterial..
Relevance: 84.21038
  • eleison-pharma.com
  • 1
  • 1
  • 7
We are a clinical stage, specialty pharmaceutical company focused on developing drug candidates for "orphan" oncology indications that potentially address areas of high unmet medical need in the treatment of cancer. Our strategy is to acquire late-..
Relevance: 83.56832
  • pharma2b.com
  • 1
  • 14
Pharma Two B is a private, late clinical-stage pharmaceutical company established in 2007 in Rehovot, Israel... Pharma Two B aims to utilize the shortened FDA approval timelines via the US 505(b)(2) regulatory pathway, reserved for candidates, who..
Relevance: 82.756256
  • soft-ox.com
  • 4
  • 1
  • 9
SoftOx Solutions AS is a medtech and clinical-stage pharmaceutical company, founded in 2012. After years of research and product development with leading Nordic research institutions, SoftOx has developed a non-toxic and highly efficient antiseptic..
Relevance: 80.970314
  • www.canceradvances.com
  • 1
  • 3
Cancer Advances is focused on developing therapeutics for gastrin/ gastrin receptor (CCKB) producing tumors. The company's lead product, Polyclonal Antibody Stimulator (PAS), is an immunomodulator that blocks the function of gastrin. This inhibition..
Relevance: 80.77736
  • www.azoratherapeutics.com
Azora Therapeutics is a clinical-stage biopharmaceutical company developing novel small molecule new chemical entities for the treatment of autoimmune, inflammatory diseases. Our team has decades of experience in drug development and has helped..
Relevance: 79.38357
  • kempharm.com
  • 3
  • 3
  • 14
KemPharm® is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs that are designed to be improved versions of widely prescribed, approved drugs... KemPharm's prodrug product candidate..
Relevance: 78.886284
  • www.micropharm.co.uk
  • 1
  • 1
MicroPharm is a commercial and clinical stage specialty pharmaceutical company with several proprietary technology platforms focussed on the development and commercialisation of specifically targeted polyclonal antibodies. MicroPharm has two..
Relevance: 78.75951
  • kiorapharma.com
  • 2
  • 2
  • 20
Kiora is a clinical-stage biotechnology company developing and commercializing products for treating ophthalmic diseases. KIO-301 is a molecular photoswitch that has the potential to restore light perception in patients with inherited and/or age-..
Relevance: 78.53014
  • kiorapharma.com
  • 2
  • 19
Kiora Pharmaceuticals (NASDAQ: KPRX) is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. KIO-301 is being developed for the treatment of Retinitis Pigmentosa, and Kiora also..
Relevance: 77.711716
  • mediprintlens.com
  • 2
  • 1
  • 11
Our goal is to change the standard of care for successfully delivering ocular drugs to the eye non-invasively. We will use our patented MediPrint™ process to offer a unique value proposition for patients, eye care professionals, strategic partners..
Relevance: 76.63846
  • mediprintlens.com
  • 2
  • 1
  • 11
MediPrint™ Ophthalmics is an emerging San Diego-based clinical stage eye care pharmaceutical company developing and commercializing a proprietary ocular drug delivery portfolio... Our goal is to change the standard of care for successfully..
Relevance: 76.63846
  • www.inhibikase.com
  • 3
  • 3
  • 14
We are Inhibikase Therapeutics, a pharmaceutical company innovating small-molecule kinase inhibitor therapeutics to treat Parkinson's disease, Parkinson's-related neurodegenerative diseases and other diseases caused by dysfunction of the Abelson..
Relevance: 75.3176